The US government initiated a phased withdrawal of the President's Emergency Plan for AIDS Relief (PEPFAR) from South Africa. The decision cuts roughly $400 million in annual funding, which has led to the closure of local clinics, distributions in antiretroviral (ARV) medication distribution , and widespread concerns about rising infection rates.
Funding and Aid Cuts: The US State Department linked the withdrawal to policy disagrements and administration's belief that South Africa, as a middle -income country, should be self-reliant.
Impactts on patients: The funding cuts have forced the closure of multiple mobile and rural clinics. This has left tens of thousands of vulnerable patients without access to care and disrupted vital services for both HIV treatment and prevention (like PrEP).
Local Response: South African health officials have downplayed the crisis, asserting the country's capability to continue funding and distributing lifesaving drugs with its own resources. However, global health organisations like UNAIDS have expressed severe concern over the potential loss of life.